Key facts
- This page summarizes Ram Mukunda's Form 4 filing for IGC Pharma, Inc. (IGC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Sep 2026, 16:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
Gift
Additional SEC filing notes
Footnote F1
Reporting Person's two children who do not share the Reporting Person's household.